Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
SPMIP3 pseudogene 1 (SPMIP3P1) is a human pseudogene, meaning it is a segment of DNA that resembles a functional gene but has lost its gene expression or protein-coding ability owing to mutations such as frame shifts or premature stop codons. While some pseudogenes are implicated in gene regulation or disease through mechanisms such as acting as microRNA decoys or producing noncoding RNAs, there is no evidence or functional annotation indicating that SPMIP3P1 plays such a biological role. The gene bears alternative names such as C1orf100P1 and is cataloged in gene databases, but it is not considered a therapeutic target, receptor, enzyme, or disease biomarker. No data indicate SPMIP3P1 is relevant in drug targeting, disease, or molecular diagnostics and there are no known interacting molecules or drugs. It is best classified simply as a processed or nonfunctional pseudogene.
None
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on SPMIP3 pseudogene 1 (SPMIP3P1).